These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 37574645

  • 1. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis.
    Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D.
    Int J Drug Policy; 2023 Oct; 120():104157. PubMed ID: 37574645
    [Abstract] [Full Text] [Related]

  • 2. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G.
    Subst Abuse Treat Prev Policy; 2022 Oct 08; 17(1):66. PubMed ID: 36209227
    [Abstract] [Full Text] [Related]

  • 3. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M, Foreman-Mackey A, Ivsins A, Bardwell G.
    Harm Reduct J; 2023 Apr 28; 20(1):61. PubMed ID: 37118799
    [Abstract] [Full Text] [Related]

  • 4. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis.
    Kolla G, Pauly B, Cameron F, Hobbs H, Ranger C, McCall J, Majalahti J, Toombs K, LeMaistre J, Selfridge M, Urbanoski K.
    Harm Reduct J; 2024 Jun 07; 21(1):111. PubMed ID: 38849866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.
    Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC.
    Int J Drug Policy; 2024 Sep 07; 131():104547. PubMed ID: 39159532
    [Abstract] [Full Text] [Related]

  • 7. Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.
    Pauly BB, Kurz M, Dale LM, Macevicius C, Kalicum J, Pérez DG, McCall J, Urbanoski K, Barker B, Slaunwhite A, Lindsay M, Nosyk B.
    J Subst Use Addict Treat; 2024 Jun 07; 161():209341. PubMed ID: 38490334
    [Abstract] [Full Text] [Related]

  • 8. Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada.
    Speed KA, Choi J, Felicella G, Sedgemore KO, Mok WY, Milloy MJ, DeBeck K, Kerr T, Hayashi K.
    Int J Drug Policy; 2024 Oct 07; 132():104564. PubMed ID: 39236550
    [Abstract] [Full Text] [Related]

  • 9. Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.
    McCall J, Hobbs H, Ranger C, Cameron F, Stuart H, Nelken J, Majalahti J, Urbanoski K, Kolla G, LeMaistre J, Toombs K, Herriot R, Pauly B.
    Subst Abuse Treat Prev Policy; 2024 Mar 05; 19(1):19. PubMed ID: 38444035
    [Abstract] [Full Text] [Related]

  • 10. Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada.
    Urbanoski KA, van Roode T, Selfridge M, Hogan KC, Fraser J, Lock K, McGreevy PB, Burmeister C, Barker B, Slaunwhite A, Nosyk B, Pauly B.
    Subst Abuse Treat Prev Policy; 2024 Sep 16; 19(1):44. PubMed ID: 39285270
    [Abstract] [Full Text] [Related]

  • 11. "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
    Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N.
    Int J Drug Policy; 2022 Aug 16; 106():103742. PubMed ID: 35679695
    [Abstract] [Full Text] [Related]

  • 12. Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada.
    Gagnon M, Rudzinski K, Guta A, Schmidt RA, Kryszajtys DT, Kolla G, Strike C.
    Harm Reduct J; 2023 Jun 28; 20(1):81. PubMed ID: 37380995
    [Abstract] [Full Text] [Related]

  • 13. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A, MacKinnon L, Bowles JM, Slaunwhite A, Bardwell G.
    J Urban Health; 2022 Oct 28; 99(5):855-864. PubMed ID: 36044156
    [Abstract] [Full Text] [Related]

  • 14. Safer opioid supply: qualitative program evaluation.
    Haines M, O'Byrne P.
    Harm Reduct J; 2023 Apr 20; 20(1):53. PubMed ID: 37081500
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H, Haywood B, McDougall J, Xavier CG, Desai R, Tobias S, Burgess H, Ferguson M, Liu L, Kinniburgh B, Slaunwhite AK, Crabtree A, Buxton JA.
    Harm Reduct J; 2024 Jan 06; 21(1):5. PubMed ID: 38184576
    [Abstract] [Full Text] [Related]

  • 16. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
    Kolla G, Tarannum CN, Fajber K, Worku F, Norris K, Long C, Fagundes R, Rucchetto A, Hannan E, Kikot R, Klaiman M, Firestone M, Bayoumi A, Laurence G, Hayman K.
    Harm Reduct J; 2024 Jan 20; 21(1):17. PubMed ID: 38243267
    [Abstract] [Full Text] [Related]

  • 17. Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study.
    Coulaud PJ, Chayama KL, Schwartz C, Purdie A, Lysyshyn M, Ti L, Knight R.
    Harm Reduct J; 2024 Apr 27; 21(1):87. PubMed ID: 38678256
    [Abstract] [Full Text] [Related]

  • 18. Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada.
    Michaud L, Kolla G, Rudzinski K, Guta A.
    Int J Drug Policy; 2024 May 27; 127():104423. PubMed ID: 38642543
    [Abstract] [Full Text] [Related]

  • 19. Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs.
    Ivsins A, Bowles JM, Mansoor M, Kerr T, Bardwell G.
    Int J Drug Policy; 2024 Nov 27; 133():104601. PubMed ID: 39378778
    [Abstract] [Full Text] [Related]

  • 20. Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces.
    Morris H, Bwala H, Wesley J, Hyshka E.
    Can J Public Health; 2023 Jun 27; 114(3):484-492. PubMed ID: 36689127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.